CME Group Inc. (NASDAQ:CME) Shares Acquired by Pinnacle Associates Ltd.

Pinnacle Associates Ltd. raised its stake in shares of CME Group Inc. (NASDAQ:CMEGet Rating) by 17.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,528 shares of the financial services provider’s stock after purchasing an additional 977 shares during the quarter. Pinnacle Associates Ltd.’s holdings in CME Group were worth $1,156,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of CME. Parnassus Investments LLC increased its stake in shares of CME Group by 3.1% in the second quarter. Parnassus Investments LLC now owns 6,167,160 shares of the financial services provider’s stock worth $1,262,418,000 after acquiring an additional 187,304 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd increased its stake in shares of CME Group by 1.1% in the second quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,195,042 shares of the financial services provider’s stock worth $858,725,000 after acquiring an additional 44,252 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of CME Group by 10.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,732,293 shares of the financial services provider’s stock worth $764,000,000 after acquiring an additional 349,520 shares during the period. Fiera Capital Corp increased its stake in shares of CME Group by 1.5% in the second quarter. Fiera Capital Corp now owns 3,437,390 shares of the financial services provider’s stock worth $703,634,000 after acquiring an additional 52,458 shares during the period. Finally, Amundi increased its stake in shares of CME Group by 0.9% in the second quarter. Amundi now owns 2,633,574 shares of the financial services provider’s stock worth $525,475,000 after acquiring an additional 23,261 shares during the period. Institutional investors and hedge funds own 85.09% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $175.62 on Monday. CME Group Inc. has a 12-month low of $166.54 and a 12-month high of $256.94. The stock has a market cap of $63.18 billion, a P/E ratio of 23.89, a PEG ratio of 3.53 and a beta of 0.40. The company has a 50-day moving average price of $173.93 and a 200 day moving average price of $185.09. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings data on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.05. CME Group had a net margin of 54.01% and a return on equity of 10.06%. The firm had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Sell-side analysts anticipate that CME Group Inc. will post 7.94 earnings per share for the current year.

CME Group Increases Dividend

The business also recently declared a None dividend, which will be paid on Wednesday, January 18th. Shareholders of record on Wednesday, December 28th will be given a dividend of $4.50 per share. The ex-dividend date of this dividend is Tuesday, December 27th. This is a boost from CME Group’s previous None dividend of $3.25. CME Group’s dividend payout ratio (DPR) is currently 54.42%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research reports. Piper Sandler cut their price objective on shares of CME Group from $270.00 to $250.00 and set an “overweight” rating on the stock in a research note on Monday, December 19th. Rosenblatt Securities lowered their price target on shares of CME Group from $171.00 to $161.00 and set a “sell” rating on the stock in a report on Wednesday, October 5th. StockNews.com initiated coverage on shares of CME Group in a report on Wednesday, October 12th. They set a “hold” rating on the stock. UBS Group decreased their price objective on shares of CME Group from $226.00 to $220.00 in a report on Thursday, January 5th. Finally, Citigroup decreased their price objective on shares of CME Group from $214.29 to $210.00 in a report on Thursday. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $221.40.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard purchased 48,645 shares of the company’s stock in a transaction on Friday, November 4th. The stock was acquired at an average cost of $170.00 per share, for a total transaction of $8,269,650.00. Following the completion of the transaction, the director now directly owns 247,843 shares in the company, valued at $42,133,310. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.30% of the company’s stock.

About CME Group

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.